The ultra-high-end CT scanners market is expected to reach USD 10.69 billion by 2034. Rising chronic disease prevalence and extraordinary advances in photon-counting technology are driving this growth, underscoring the global call for early and accurate diagnostic tools.

In a Phase 2a trial, INF904 demonstrated strong results for HS and CSU, with no safety signals reported. Early findings from this study suggest a potentially encouraging therapy option for these challenging conditions.

On December 1, 2025, Montreal’s Samuel De Champlain Bridge will glow a striking red from sunset onward. The colors commemorate World AIDS Day and Indigenous AIDS Awareness Week, shining a spotlight on international and local public health efforts.

A groundbreaking community laboratory in Wilmington, Delaware, is now growing patient-derived “mini tumors” to guide future cancer treatments. ChristianaCare’s new organoid core—described as the first-of-its-kind—could help pave the way for more precise therapies.

In an historic decision, the U.S. Food and Drug Administration has approved Itvisma, an adeno-associated virus vector-based gene therapy for spinal muscular atrophy. By extending eligibility to adults and children two years of age and older, this new treatment offers fresh hope for families coping with the disease.

Grueling treatments and social stigma define the challenges faced by TB patients in San Antonio. In October, survivors shared their stories with researchers, shedding light on the complexities of this disease and the resilience required to overcome it.

An unexpected vertigo attack in 2015 turned one writer’s life upside down, underscoring the steep challenges of treating chronic health issues. Through physical therapy, she regained some stability. Now, she calls upon society to recognize the importance of accessible, affordable health care coverage.

Emerging research suggests that starting hormone replacement therapy at the right moment could help maintain estrogen levels and reduce the risk of dementia in women. Doctors are investigating how timing may be key to safeguarding cognitive function.

GC Genome and Asan Medical Center have published their collaborative findings on a blood-based colorectal cancer screening method. The study, now featured in The American Journal of Gastroenterology, highlights the promise of liquid biopsy techniques in improving early cancer detection.

Doctors and researchers have long recognized that our immune system has the potential to fight cancer. Recent breakthroughs have finally allowed that principle to evolve into powerful, immune-based therapies that bring renewed hope.

Thanksgiving is a time for family, friends, and feasting—yet foodborne illnesses can quickly dampen the holiday spirit. This article underscores the vital role of proper precautions to ensure a joyful and healthy holiday celebration.

A live Charlotte Talks recording event is set to revisit the 1944 polio epidemic in Catawba County, examining how a close-knit community rallied in record time. This swift collaboration became known across North Carolina as the “Miracle of Hickory,” a testament to the power of unity against a public health threat.

Scientific research, once considered a bedrock of progress, is marred by retractions and fraudulent data. From AI-generated “findings” to dubious funding sources, a wave of deception threatens the credibility of modern science and undermines public trust.

In a surprising move, the U.S. government has halted $500 million in funding for groundbreaking mRNA vaccines. This decision comes despite mRNA technology’s strong record of saving millions of lives from respiratory threats like COVID-19 and the flu.

A new generation of portable oxygen concentrators aims to give people on oxygen therapy greater freedom. Inogen’s devices let users keep an active lifestyle while receiving necessary medical support. Learn how to access a free information kit to explore these mobile solutions.

The Hawaiian Humane Society is urgently seeking community support after witnessing a marked rise in feline panleukopenia cases. This highly contagious disease has led to an influx of affected cats and kittens in the shelter’s care, underscoring the need for swift action and resources.

A transformative partnership between Lunit and Labcorp promises to accelerate digital pathology innovations through artificial intelligence. By combining Lunit’s expertise in AI-driven cancer diagnostics with Labcorp’s extensive laboratory services, the collaboration aims to support new breakthroughs in oncology research and clinical care.

Chikungunya’s appearance in New York is a wake-up call to pay attention to insect-borne illnesses. Public health experts urge concern but caution against panic, highlighting the need to stay informed and aware.

A recent Penn State study has identified significantly higher melanoma rates in 15 Pennsylvania counties that contain or are near farmland. The research raises concerns about possible environmental factors unique to these areas.

Scientists are exploring the possible role of reptile urine in preventing some of the most painful health issues humans face: kidney stones and gout. This surprising line of research focuses on how snakes and lizards manage uric acid and what it might mean for human medicine.

Team Novo Nordisk, the world’s first all-diabetes professional cycling team, has confirmed a five-year extension of its ongoing partnership with global healthcare leader Novo Nordisk. Announced on World Diabetes Day, this move extends the collaboration through 2031 and underscores their continued commitment to reshaping perceptions of diabetes worldwide.